Epidermal growth factor receptor-containing exosomes induce tumor-specific regulatory T cells

Cancer Investigation

Volumn 31, Issue 5, 2013, Pages 330-335

  Huang, Shao Hong ^a   Li, Yun ^a   Zhang, Jian ^a   Rong, Jian ^b   Ye, Sheng ^b  

^a Department of Cardiothoracic Surgery of the Third Affiliated Hospital ^*  (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Dendritic cell; Epidermal growth factor receptor; Lung cancer; Regulatory T cell; Tumor tolerance

Indexed keywords

GROWTH FACTOR RECEPTOR;

ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; EXOSOME; HUMAN; HUMAN TISSUE; LUNG CANCER; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH0 CELL;

ANTIGENS, NEOPLASM; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; EXOSOMES; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LUNG NEOPLASMS; PNEUMONIA; RECEPTOR, EPIDERMAL GROWTH FACTOR; T-LYMPHOCYTES, REGULATORY;

EID: 84877947179     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2013.789905     Document Type: Article

References (22)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Qin FX. Dynamic behavior and function of Foxp3+ regulatory T cells in tumor bearing host. Cell Mol Immunol 2009;6(1):3-13.
3. Olayioye MA, Neve RM, Lane HA, Hynes NE. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 2000;19:3159-3167. (Pubitemid 30428195)
4. Gullick WJ. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 1991;47:87-98.
5. Abou-Seri SM. Synthesis and biological evaluation of novel 2, 4'-bis substituted diphenylamines as anticancer agents and potential epidermal growth factor receptor tyrosine kinase inhibitors. Eur J Med Chem 2010;45:4113-4121.
6. Murray S, Karavasilis V, Bobos M, Razis E, Papadopoulos S, Christodoulou C, Kosmidis P, Fountzilas G. Molecular predictors of response to tyrosine kinase inhibitors in patients with non-small-cell lung cancer. J Exp Clin Cancer Res 2012;31:77.
7. Tiaka EK, Papanas N, Manolakis AC, Georgiadis GS. Epidermal growth factor in the treatment of diabetic foot ulcers: an update. Perspect Vasc Surg Endovasc Ter 2012;24:37-44.
8. da Silva Ll, Neves BM, Moura L, Cruz MT, Carvalho EN. Neu-rotensin downregulates the pro-infammatory properties of skin dendritic cells and increases epidermal growth factor expression. Biochim Biophys Acta 2011;1813:1863-1871.
9. Cho JA, Park H, Lim EH, Kim KH, Choi JS, Lee JH, Shin JW, Lee KW. Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofbroblasts. Gy-necol Oncol 2011;123:379-386.
10. Li TL, Zhang SY, Du YC, Yang PC. Defciency of ubiquitin A20 promotes antigen transport across airway epithelial cells via a transcellular pathway. Anal Biochem 2013;433:86-91.
11. Chen X, Song CH, Feng BS, Li TL, Li P, Zheng PY, Chen XM, Xing Z, Yang PC. Intestinal epithelial cell-derived integrin alphavbetaβ6 plays an important role in the induction of regulatory T cells and inhibits an antigen-specifc T2 response. J Leukoc Biol 2011;90:751-759.
12. Zech D, Rana S, Buchler M, Zoller M. Tumor-exosomes and leukocyte activation: an ambivalent crosstalk. Cell Commun Signal 2012;10:37.
13. Liu T, He SH, Zheng PY, Zhang TY, Wang BQ, Yang PC. Staphy-lococcal enterotoxin B increases TIM4 expression in human dendritic cells that drives naive CD4 T cells to diferentiate into T2 cells. Mol Immunol 2007;44:3580-3587. (Pubitemid 46754437)
14. Yamada T, Takeuchi S, Fujita N, Nakamura A, Wang W, Li Q, Oda M, Mitsudomi T, Yatabe Y, Sekido Y, Yoshida J, Higashiyama M, Noguchi M, Uehara H, Nishioka Y, Sone S, Yano S. Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations. Oncogene 2012; doi: 10.1038/onc.2012.446.
15. Ogasawara N, Oguro T, Sakabe T, Matsushima M, Takikawa O, Isobe KI, Nagase F. Hemoglobin induces the expression of in-doleamine 2, 3-dioxygenase in dendritic cells through the activation of PI3K, PKC, and NF-kappa B and the generation of reactive oxygen species. J Cell Biochem 2009;108:716-725.
16. Park MJ, Min SY, Park KS, Cho YG, Cho ML, Jung YO, Park HS, Chang SH, Cho S, Min JK, Park SH, Kim HY. Indoleamine 2, 3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model. Arthritis Res Ter 2008;10:R11.
17. Ellison G, Zhu G, Moulis A, Dearden S, Speake G, McCormack R. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples. J Clin Pathol 2013;66:79-89.
18. Chen X, Song CH, Feng BS, Li TL, Li P, Zheng PY, Chen XM, Xing Z, Yang PC. Intestinal epithelial cell-derived integrin avß6 plays an important role in the induction of regulatory T cells and inhibits an antigen-specifc T2 response. J Leukoc Biol 2011;90:751-759.
19. Fallarino F, Grohmann U, Puccetti P. Indoleamine 2, 3-dioxygenase: from catalyst to signaling function. Eur J Immunol 2012;42:1932-1937.
20. Ino K. Indoleamine 2, 3-dioxygenase and immune tolerance in ovarian cancer. Curr Opin Obstet Gynecol 2011;23:13-18.
21. He SH, Chen X, Song CH, Liu ZQ, Zhou LF, Ma WJ, Zhao LD, Li TL, Tang SG, Xing Z, Yang PC. Interferon-lambda mediates oral tolerance and inhibits antigen-specifc, T-helper 2 cell-mediated infammation in mouse intestine. Gastroenterology 2011;141:249-258.
22. Park MJ, Park KS, Park HS, Cho ML, Hwang SY, Min SY, Park MK, Park SH, Kim HY. A distinct tolerogenic subset of splenic IDO+CD11b+ dendritic cells from orally tolerized mice is responsible for induction of systemic immune tolerance and suppression of collagen-induced arthritis. Cell Immunol 2012;278:45-54.